[
    "{\"step_by_step_thinking\": \"To determine whether dacomitinib should be used for treatment of glioblastoma patients, we need to consider the available evidence and guidelines. Glioblastoma is a type of brain cancer that is typically treated with a combination of surgery, radiation therapy, and chemotherapy. Dacomitinib is a targeted therapy that inhibits the activity of certain proteins involved in cancer growth. However, it is important to note that dacomitinib is not currently approved by the FDA for the treatment of glioblastoma. To make a definitive decision, we would need to review clinical trials and guidelines specific to glioblastoma treatment.\", \"answer_choice\": \"B. no\"}"
]